BROOKE FROST: Open Payments
NPI 1366103327 · POINT PLEASANT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 37 payments from 15 companies in 2025. Trend: 2023 $542 · 2024 $833 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $173 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Astellas Pharma US Inc | 3 | $66 |
| Dexcom, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| ABBVIE INC. | 2 | $29 |
| Corcept Therapeutics | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
Products named: Ozempic, Wegovy, Veozah, AIRSUPRA, RELISTOR, Dexcom G6 Transmitter, XIFAXAN, TRELEGY ELLIPTA.
Industry payments across WV — which companies pay providers there.
